Boston Partners grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 29.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 158,348 shares of the medical research company’s stock after purchasing an additional 36,161 shares during the quarter. Boston Partners owned approximately 0.06% of Agilent Technologies worth $27,285,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of A. Independent Advisor Alliance raised its position in shares of Agilent Technologies by 412.6% in the third quarter. Independent Advisor Alliance now owns 7,992 shares of the medical research company’s stock valued at $1,387,000 after buying an additional 6,433 shares during the last quarter. Composition Wealth LLC boosted its position in Agilent Technologies by 8.8% during the third quarter. Composition Wealth LLC now owns 4,415 shares of the medical research company’s stock worth $761,000 after acquiring an additional 357 shares during the last quarter. Global Retirement Partners LLC grew its stake in Agilent Technologies by 32.2% during the 3rd quarter. Global Retirement Partners LLC now owns 4,813 shares of the medical research company’s stock valued at $829,000 after acquiring an additional 1,171 shares in the last quarter. Rothschild Investment LLC grew its stake in Agilent Technologies by 0.6% during the 3rd quarter. Rothschild Investment LLC now owns 12,561 shares of the medical research company’s stock valued at $2,164,000 after acquiring an additional 79 shares in the last quarter. Finally, Cibc World Market Inc. raised its holdings in Agilent Technologies by 47.9% in the 3rd quarter. Cibc World Market Inc. now owns 42,474 shares of the medical research company’s stock valued at $7,319,000 after acquiring an additional 13,763 shares during the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.
Agilent Technologies Stock Performance
NYSE:A opened at $170.10 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The firm has a market capitalization of $47.96 billion, a price-to-earnings ratio of 33.48, a PEG ratio of 2.50 and a beta of 1.24. The company’s 50-day moving average is $171.13 and its two-hundred day moving average is $139.19. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $182.99.
Agilent Technologies Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 27th. Stockholders of record on Tuesday, January 5th will be issued a dividend of $0.2625 per share. The ex-dividend date is Tuesday, January 5th. This represents a $1.05 dividend on an annualized basis and a dividend yield of 0.6%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.2550. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.67%.
Wall Street Analyst Weigh In
A number of research firms have weighed in on A. Deutsche Bank began coverage on shares of Agilent Technologies in a research note on Monday, October 26th. They issued a “buy” rating and a $190.00 target price on the stock. Evercore upped their price target on Agilent Technologies from $148.00 to $178.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. The Goldman Sachs Group increased their price target on Agilent Technologies from $175.00 to $185.00 and gave the company a “buy” rating in a report on Monday, September 21st. Morgan Stanley lifted their price objective on Agilent Technologies from $175.00 to $190.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 13th. Finally, Bank of America boosted their price objective on Agilent Technologies from $180.00 to $190.00 in a research note on Friday, October 9th. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $181.45.
Check Out Our Latest Report on Agilent Technologies
Insider Buying and Selling at Agilent Technologies
In related news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This trade represents a 11.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.17% of the company’s stock.
About Agilent Technologies
Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.
Featured Articles
- Five stocks we like better than Agilent Technologies
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
